The global colostrum market size is expected to be valued at US$ 3.6 billion in 2026 and projected to reach US$ 5.8 billion by 2033, growing at a CAGR of 7.0% between 2026 and 2033.
The market expansion is driven by rising consumer awareness regarding immunity-boosting properties of colostrum, particularly following heightened health consciousness post-pandemic. Scientific validation of colostrum's high concentration of immunoglobulins (IgA and IgG), growth factors, lactoferrin, and bioactive compounds has strengthened its position as a natural health solution. According to research published in Science Direct, bovine colostrum demonstrates anti-inflammatory and gut-repairing properties beneficial for gastrointestinal disorders, including inflammatory bowel disease and leaky gut syndrome, driving significant adoption in dietary supplements. The increasing prevalence of digestive health issues globally, combined with the growing demand for preventive healthcare solutions across developed and emerging markets, continues to propel market growth.